Analyst Viewpoint
Rise in prevalence of chronic diseases and genetic disorders is a primary factor contributing to the microarray scanners market growth. Increase in geriatric population, surge in adoption of unhealthy lifestyle, rise in environmental pollution, and genetic issues and work stress are augmenting the cases of cancer, diabetes, and several genetic disorders.
Healthcare systems across the world are adapting to evolving demographics and personalized patient needs, thus fueling the microarray scanner industry.
Constant advancements in genetic research are propelling the microarray scanners industry size. Growth in awareness about the risk of genetic diseases and cancer treatment methods has led to high government investments in genomic research to prevent, predict, diagnose, and cure several illnesses.
Microarray scanners market manufacturers are developing protein and gene expression equipment to cater to the growing demand from hospitals and research institutions.
Microarray scanners are sophisticated medical instruments utilized for genetic analysis to identify and quantify thousands of genes simultaneously to predict, prevent, diagnose, and cure chronic illnesses and disorders, including several types of cancer.
These devices offer a high-throughput capability that allows researchers to analyze a large amount of genetic and protein data. This data is further utilized in diverse fields such as biomedical research, drug discovery, agricultural biotechnology, and clinical diagnostics.
Microarrays are critical components in genetic and cancer treatment research, as they offer assistance in identifying biomarkers, comprehending diseases or illness mechanisms, and expanding upon genomic patterns.
Recent microarray scanners market analysis indicates a trend toward the incorporation of automation and advanced sequencing & single-cell studies to improve precision, sensitivity, and resolution of devices.
Significant growth in geriatric population, rise in environmental degradation, increase in adoption of modern sedentary lifestyle, and genetic predispositions are critical factors leading to growth in prevalence of chronic diseases and genetic disorders.
Work stress and unhealthy habits such as smoking and drinking increase the penetration of chronic illnesses, including diabetes and cancer. Additionally, genetic disorders are unique, as they can exist as birth defects or occur in later stages of life.
As per data publicly made available by the Centers for Disease Control and Prevention (CDC), approximately half of American adults suffer from at least one chronic disease. Furthermore, the old age demographic is set to account for 40% of the population by 2040, thus enhancing the burden on the healthcare system.
Global healthcare systems need to adapt and expand to meet the needs of the elderly by investing in innovative technologies and personalized therapies to ensure safe, accessible, and affordable genetic diagnostic solutions for a demographic that usually has more than one ailment at once.
Constant innovations in genomic research such as development of personalized treatments, discovery of novel genetic biomarkers, and expansion of the human genome are fueling microarray scanners business opportunities.
Rise in awareness about healthcare processes, especially post the COVID-19 pandemic, and accessible genome-based cancer treatments have resulted in an increase in demand for optimal diagnosis and prevention care. This has led to a surge in R&D spending on genomic research.
Globally, nearly US$ 3.0 Bn is spent every year on genetics research, with an estimated half of the funding being allocated by governments worldwide. Among countries that have a higher population of older people and higher chronic disease risk, China considers genetic research a priority.
In 2020, the Government of China passed a law termed the ‘National Biosecurity Law,’ which gives the government complete legal sovereignty over the genetic data of Chinese citizens.
North America held the largest microarray scanners market share in 2022. Surge in adoption of advanced genomic analysis technologies and increase in healthcare expenditure are augmenting the market statistics of the region.
The American Association for Cancer Research states that cancer care costs in the U.S. are expected to exceed US$ 245.0 Bn by 2030.
According to the latest microarray scanners market regional insights, the industry in Asia Pacific is projected to grow at a steady pace from 2023 to 2031. Increase in cases of genetic disorders and DNA-related chronic diseases is propelling microarray scanners industry development in the region.
As per the Government of India’s Union Ministry of Health and Family Welfare, nearly 6% to 8% of the population in the country suffers from rare genetic disorders.
Prominent manufacturers of microarray scanners are investing substantially in gene expression microarray scanners and protein microarray scanners to improve the detection of antibodies and address novel infections.
Thermo Fisher Scientific Inc., Agilent Technologies, Illumina, Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare (General Electric Company), Molecular Devices, LLC. (Danaher Corporation), Innopsys Inc., and Berthold Technologies GmbH & Co. KG are the leading companies operating in the global industry.
The microarray scanners market report highlights various parameters such as business strategies, company overview, product portfolio, financial overview, and business segments of these companies.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 919.9 Mn |
| Market Forecast Value in 2031 | US$ 1.7 Bn |
| Growth Rate (CAGR) | 7.5% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn/Bn for Value and Units for Volume |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 919.9 Mn in 2022
It is projected to grow at a CAGR of 7.5% from 2023 to 2031
Rise in prevalence of chronic diseases and genetic disorders, and advancements in genomic research
The fluorescence microarray scanners segment accounted for the largest share in 2022
North America was the leading region in 2022
Thermo Fisher Scientific Inc., Agilent Technologies, Illumina, Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare (General Electric Company), Molecular Devices, LLC. (Danaher Corporation), Innopsys Inc., and Berthold Technologies GmbH & Co. KG.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Microarray Scanners Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Microarray Scanners Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Microarray Scanners Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Fluorescence Microarray Scanners
6.3.2. Charge-coupled Devices Microarray Scanners
6.3.3. Colorimetric Microarray Scanners
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Microarray Scanners Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Gene Expression
7.3.2. Drug Discovery
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Microarray Scanners Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Pharmaceutical & Biotechnology Companies
8.3.4. Academic & Research Institutes
8.4. Market Attractiveness Analysis, by End-user
9. Global Microarray Scanners Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Microarray Scanners Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Fluorescence Microarray Scanners
10.3.2. Charge-coupled Devices Microarray Scanners
10.3.3. Colorimetric Microarray Scanners
10.3.4. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Gene Expression
10.4.2. Drug Discovery
10.4.3. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Diagnostic Laboratories
10.5.3. Pharmaceutical & Biotechnology Companies
10.5.4. Academic & Research Institutes
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By End-user
10.7.3. By Country
11. Europe Microarray Scanners Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Fluorescence Microarray Scanners
11.3.2. Charge-coupled Devices Microarray Scanners
11.3.3. Colorimetric Microarray Scanners
11.3.4. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Gene Expression
11.4.2. Drug Discovery
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Diagnostic Laboratories
11.5.3. Pharmaceutical & Biotechnology Companies
11.5.4. Academic & Research Institutes
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By End-user
11.7.3. By Country/Sub-region
12. Asia Pacific Microarray Scanners Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Fluorescence Microarray Scanners
12.3.2. Charge-coupled Devices Microarray Scanners
12.3.3. Colorimetric Microarray Scanners
12.3.4. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Gene Expression
12.4.2. Drug Discovery
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Diagnostic Laboratories
12.5.3. Pharmaceutical & Biotechnology Companies
12.5.4. Academic & Research Institutes
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By End-user
12.7.3. By Country/Sub-region
13. Latin America Microarray Scanners Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Fluorescence Microarray Scanners
13.3.2. Charge-coupled Devices Microarray Scanners
13.3.3. Colorimetric Microarray Scanners
13.3.4. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Gene Expression
13.4.2. Drug Discovery
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Diagnostic Laboratories
13.5.3. Pharmaceutical & Biotechnology Companies
13.5.4. Academic & Research Institutes
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By End-user
13.7.3. By Country/Sub-region
14. Middle East & Africa Microarray Scanners Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Fluorescence Microarray Scanners
14.3.2. Charge-coupled Devices Microarray Scanners
14.3.3. Colorimetric Microarray Scanners
14.3.4. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Gene Expression
14.4.2. Drug Discovery
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Diagnostic Laboratories
14.5.3. Pharmaceutical & Biotechnology Companies
14.5.4. Academic & Research Institutes
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By End-user
14.7.3. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Agilent Technologies
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Illumina, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. PerkinElmer, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. F. Hoffmann-La Roche Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. GE Healthcare (General Electric Company)
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Molecular Devices, LLC. (Danaher Corporation)
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Innopsys Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Berthold Technologies GmbH & Co. KG.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 1: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 2: Global Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2017–2031
Table 3: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 4: Global Microarray Scanners Market Volume (Units) Forecast, by Application, 2017–2031
Table 5: Global Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 6: Global Microarray Scanners Market Volume (Units) Forecast, by End-user, 2017–2031
Table 7: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 8: Global Microarray Scanners Market Volume (Units) Forecast, by Region, 2017–2031
Table 9: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 10: North America Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2017–2031
Table 11: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: North America Microarray Scanners Market Volume (Units) Forecast, by Application, 2017–2031
Table 13: North America Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 14: North America Microarray Scanners Market Volume (Units) Forecast, by End-user, 2017–2031
Table 15: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 16: North America Microarray Scanners Market Volume (Units) Forecast, by Country, 2017–2031
Table 17: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Europe Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2017–2031
Table 19: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Europe Microarray Scanners Market Volume (Units) Forecast, by Application, 2017–2031
Table 21: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 22: Europe Microarray Scanners Market Volume (Units) Forecast, by End-user, 2017–2031
Table 23: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Europe Microarray Scanners Market Volume (Units) Forecast, by Country/Sub-region, 2017–2031
Table 25: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 26: Asia Pacific Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2017–2031
Table 27: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Asia Pacific Microarray Scanners Market Volume (Units) Forecast, by Application, 2017–2031
Table 29: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Asia Pacific Microarray Scanners Market Volume (Units) Forecast, by End-user, 2017–2031
Table 31: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Asia Pacific Microarray Scanners Market Volume (Units) Forecast, by Country/Sub-region, 2017–2031
Table 33: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 34: Latin America Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2017–2031
Table 35: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 36: Latin America Microarray Scanners Market Volume (Units) Forecast, by Application, 2017–2031
Table 37: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 38: Latin America Microarray Scanners Market Volume (Units) Forecast, by End-user, 2017–2031
Table 39: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 40: Latin America Microarray Scanners Market Volume (Units) Forecast, by Country/Sub-region, 2017–2031
Table 41: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 42: Middle East & Africa Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2017–2031
Table 43: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 44: Middle East & Africa Microarray Scanners Market Volume (Units) Forecast, by Application, 2017–2031
Table 45: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 46: Middle East & Africa Microarray Scanners Market Volume (Units) Forecast, by End-user, 2017–2031
Table 47: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 48: Middle East & Africa Microarray Scanners Market Volume (Units) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Microarray Scanners Market Size (US$ Mn) and Distribution (%), by Region, 2023–2031
Figure 02: Global Microarray Scanners Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Microarray Scanners Market Value Share, by Product Type, 2022
Figure 04: Global Microarray Scanners Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Microarray Scanners Market Value Share, by Application, 2022
Figure 06: Global Microarray Scanners Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Microarray Scanners Market Value Share, by End-user, 2022
Figure 08: Global Microarray Scanners Market Value Share, by Region, 2022
Figure 09: Global Microarray Scanners Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Microarray Scanners Market Value Share Analysis, by Product Type, 2023–2031
Figure 11: Global Microarray Scanners Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 12: Global Microarray Scanners Market Value Share Analysis, by Application, 2023–2031
Figure 13: Global Microarray Scanners Market Attractiveness Analysis, by Application, 2022–2031
Figure 14: Global Microarray Scanners Market Value Share Analysis, by End-user, 2023–2031
Figure 15: Global Microarray Scanners Market Attractiveness Analysis, by End-user, 2022–2031
Figure 16: Global Microarray Scanners Market Value Share Analysis, by Region, 2023–2031
Figure 17: Global Microarray Scanners Market Attractiveness Analysis, by Region, 2022–2031
Figure 18: North America Microarray Scanners Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 19: North America Microarray Scanners Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Microarray Scanners Market Value Share Analysis, by Country, 2023–2031
Figure 21: North America Microarray Scanners Market Value Share Analysis, by Product Type, 2023–2031
Figure 22: North America Microarray Scanners Market Value Share Analysis, by Application, 2023–2031
Figure 23: North America Microarray Scanners Market Value Share Analysis, by End-user, 2023–2031
Figure 24: North America Microarray Scanners Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 25: North America Microarray Scanners Market Attractiveness Analysis, by Application, 2022–2031
Figure 26: North America Microarray Scanners Market Attractiveness Analysis, by End-user, 2022–2031
Figure 27: Europe Microarray Scanners Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 28: Europe Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2023–2031
Figure 30: Europe Microarray Scanners Market Value Share Analysis, by Product Type, 2023–2031
Figure 31: Europe Microarray Scanners Market Value Share Analysis, by Application, 2023–2031
Figure 32: Europe Microarray Scanners Market Value Share Analysis, by End-user, 2023–2031
Figure 33: Europe Microarray Scanners Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 34: Europe Microarray Scanners Market Attractiveness Analysis, by Application, 2022–2031
Figure 35: Europe Microarray Scanners Market Attractiveness Analysis, by End-user, 2022–2031
Figure 36: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 37: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2023–2031
Figure 39: Asia Pacific Microarray Scanners Market Value Share Analysis, by Product Type, 2023–2031
Figure 40: Asia Pacific Microarray Scanners Market Value Share Analysis, by Application, 2023–2031
Figure 41: Asia Pacific Microarray Scanners Market Value Share Analysis, by End-user, 2023–2031
Figure 42: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 43: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Application, 2022–2031
Figure 44: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by End-user, 2022–2031
Figure 45: Latin America Microarray Scanners Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 46: Latin America Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2023–2031
Figure 48: Latin America Microarray Scanners Market Value Share Analysis, by Product Type, 2023–2031
Figure 49: Latin America Microarray Scanners Market Value Share Analysis, by Application, 2023–2031
Figure 50: Latin America Microarray Scanners Market Value Share Analysis, by End-user, 2023–2031
Figure 51: Latin America Microarray Scanners Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 52: Latin America Microarray Scanners Market Attractiveness Analysis, by Application, 2022–2031
Figure 53: Latin America Microarray Scanners Market Attractiveness Analysis, by End-user, 2022–2031
Figure 54: Middle East & Africa Microarray Scanners Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 55: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2023–2031
Figure 57: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Product Type, 2023–2031
Figure 58: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Application, 2023–2031
Figure 59: Middle East & Africa Microarray Scanners Market Value Share Analysis, by End-user, 2023–2031
Figure 60: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 61: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Application, 2022–2031
Figure 62: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Microarray Scanners Market
